Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin + betamethasone ointment vs Diprogenta vs vehicle in infected eczema
2014-005519-18Phase 3Completed
- Sponsor
- Dermapharm
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gentamicin + betamethasone dipropionate in atopic dermatitis (AD) (3 arms), sponsored by Dermapharm. Primary endpoint: Clinical success rate at end of treatment. Started Oct 2015; status: completed.
02
Drugs
gentamicin + betamethasone dipropionate
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2014-005519-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005519-18.